XNAS · NEPH
-0.46% · -$0.0200 · Vol 6.8K
Live · updated 10:05:18 ET
Nephros Inc.

Nephros Inc.

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$4.29
Card
Relationship Map

Follow $NEPH

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $NEPH by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measuredMethodology
NEPH
Nephros Inc.
Fri Sep 18 · last completed session · daily score · 2d 12h old
Highest qualified

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

80/ 100
Veridion Score
Highest qualified · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: HIGH · 6 of 6 factors measured · Fri Sep 18 · last completed session · daily score · 2d 12h old
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is NEPH moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading NEPH catalysts
About Nephros Inc.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2004
Employees
36
Country
US

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$4.37
Day high
$4.37
Day low
$4.24
Previous close
$4.31
52W high
$5.79
-25.84% from high
52W low
$2.78
50% of range
Market cap
$46.8M
P/E
25.24×
EPS
$0.1700
Beta
1.19
Shares out
10.9M
Volume
6.8K
0.22× rel vol
Avg volume
31.7K
VWAP
$4.31
Price history computed in-house
1W
-3.16%
1M
+5.15%
3M
+30.00%
1Y
+2.63%
YTD
-12.09%
SMA 50 $4.04 · above
SMA 200 $3.87 · above
52W position 50%

NEPH overview

Loading financial statements
Loading NEPH Form 4 filings
Public disclosures

Congress activity in NEPH

No receipt-qualified Congressional disclosure is present for NEPH in the cached public ledger.

Federal contracts

NEPH contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for NEPH in this window.
Lobbying spend

NEPH lobbying filings, year to date.

Registered lobbying filings matched to Nephros Inc..

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for NEPH in this window.
Loading news for NEPH
Analyst ratings
Sovereign unlock shows live analyst consensus for NEPH.
Options
Sovereign unlock shows live options positioning for NEPH.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.